The combined indexes in HEC-1-B and HEC-6 endometrial cancer cell lines were 0.43 and 0.28, respectively, suggesting that the co-inhibition of ATR and CHK1 provided excellent antitumor activity in endometrial cancer [60]. The gene discussed is CHEK1; the disease is endometrial cancer.